ILK and glioblastoma: Genetic depletion of ILK expression or pharmacologic inhibition of ILK with an ILK inhibitor, Compound 22, blocked ligand-independent c-Met phosphorylation in the presence of fibronectin [43], and treatment with Compound 22 also reduced adhesion and spreading of U87 glioblastoma cells on fibronectin.